Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
AstraZeneca
Covington
Fuji
Federal Trade Commission
Harvard Business School
Farmers Insurance
QuintilesIMS
US Department of Justice
Express Scripts

Generated: October 19, 2017

DrugPatentWatch Database Preview

Ferring Pharms As Company Profile

« Back to Dashboard

What is the competitive landscape for FERRING PHARMS AS, and what generic alternatives to FERRING PHARMS AS drugs are available?

FERRING PHARMS AS has one approved drug.

There are eight US patents protecting FERRING PHARMS AS drugs.

There are eight patent family members on FERRING PHARMS AS drugs in two countries.

Summary for Applicant: Ferring Pharms As

International Patents:8
US Patents:8
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring Pharms As
LYSTEDA
tranexamic acid
TABLET;ORAL022430-001Nov 13, 2009ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Ferring Pharms As
LYSTEDA
tranexamic acid
TABLET;ORAL022430-001Nov 13, 2009ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Ferring Pharms As
LYSTEDA
tranexamic acid
TABLET;ORAL022430-001Nov 13, 2009ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Ferring Pharms As
LYSTEDA
tranexamic acid
TABLET;ORAL022430-001Nov 13, 2009ABRXYesYes► Subscribe► Subscribe ► Subscribe
Ferring Pharms As
LYSTEDA
tranexamic acid
TABLET;ORAL022430-001Nov 13, 2009ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Ferring Pharms As
LYSTEDA
tranexamic acid
TABLET;ORAL022430-001Nov 13, 2009ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Ferring Pharms As
LYSTEDA
tranexamic acid
TABLET;ORAL022430-001Nov 13, 2009ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Ferring Pharms As
LYSTEDA
tranexamic acid
TABLET;ORAL022430-001Nov 13, 2009ABRXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for FERRING PHARMS AS drugs

Drugname Dosage Strength Tradename Submissiondate
tranexamic acid
Tablets650 mg
LYSTEDA
5/24/2011

International Patent Family for Ferring Pharms As Drugs

Country Document Number Estimated Expiration
Japan2011168596► Subscribe
Japan5000504► Subscribe
Japan2014193878► Subscribe
Japan2008508276► Subscribe
Japan5205053► Subscribe
World Intellectual Property Organization (WIPO)2006023000► Subscribe
World Intellectual Property Organization (WIPO)2006023001► Subscribe
Japan2008508275► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Baxter
McKinsey
Accenture
Julphar
Fuji
Covington
Harvard Business School
Queensland Health
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot